Skip to main content
Clinical Trials/ACTRN12624000112561
ACTRN12624000112561
Recruiting
N/A

Investigating the relationship between blood pressure and gut permeability in normotensive and hypertensive patients

A/Prof Francine Marques0 sites96 target enrollmentFebruary 8, 2024

Overview

Phase
N/A
Intervention
Not specified
Conditions
High Blood Pressure
Sponsor
A/Prof Francine Marques
Enrollment
96
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 8, 2024
End Date
TBD
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
A/Prof Francine Marques

Eligibility Criteria

Inclusion Criteria

  • Ability to give informed consent.
  • 18\-75 years of age
  • BMI 18\.5\-40 kg/m2
  • Either sex
  • For normotensive participants:
  • \- Not taking antihypertensive medications AND
  • \- 24 hour ambulatory blood pressure monitoring results of Systolic blood pressure \<130 mmHg and diastolic blood pressure \<80 mmHg
  • For untreated hypertensive participants:
  • \- Not taking antihypertensive medications AND
  • \- 24 hour ambulatory blood pressure monitoring results of Systolic blood pressure \>130 mmHg and diastolic blood pressure \>80 mmHg

Exclusion Criteria

  • Alzheimers, dementia or other unsoundness of mind
  • Recent use of antibiotics (\<3 months) or probiotics (\< 6 weeks)
  • Pregnant or lactating women
  • Presence of gastrointestinal diseases (including ulcerative colitis, crohn’s disease, inflammatory bowel disease, lactose intolerance, celiac disease, chronic pancreatitis or other malabsorption disorder).
  • Previous gastrointestinal surgery.
  • Renal dysfunction with an eGFR \< 45\.
  • ADHD stimulant medications (as this may affect blood pressure)
  • Office blood pressure over/equal to 165/100 mmHg – these participants will be advised to see their GPs as guidelines suggest antihypertensive therapy should be started soon.

Outcomes

Primary Outcomes

Not specified

Similar Trials